Case Study
Axxam: Embedding sustainability at the core of healthcare scientific innovation
Axxam is a European life sciences company specializing in early-stage drug discovery and research services for the pharmaceutical and biotech sectors. Operating at the intersection of innovation and healthcare, Axxam delivers integrated target-to-lead solutions, from AI-enabled target identification to wet-lab target validation, hit identification, and hit-to-lead. Leveraging state-of-the-art experimental platforms, including New Approach Methodologies (NAMs), Axxam enables efficient progression of high-quality candidates through early discovery. The same science-driven approach is also applied to identify new bioactive compounds across crop protection, animal health, food and beverage, pet food, cosmetic, and perfume industries. All activities are grounded in sustainability across operations, partnerships, and scientific processes, contributing to improved health outcomes, responsible innovation, and long-term industry resilience.
Aligned with:
03
Good health
and well-being
09
Industry, innovation
and infrastructure
12
Responsible consumption
and production
17
Partnerships
for the goals
”At Axxam, sustainability is intrinsically linked to the way scientific innovation is generated. Our role is to ensure that early-stage discovery accelerates progress in a way that is efficient, responsible, and aligned with the long-term needs of patients and the ecosystem.
Ciriaco MaraschielloChief Executive Officer (CEO) at Axxam
Enabling innovation that drives better health outcomes
Every breakthrough begins with a decision made early. At that critical starting point, Axxam helps shape discovery with precision and responsibility, elevating the quality of what moves forward. The result is a stronger foundation for our clients to turn promising science into impactful, globally competitive therapies.
Axxam contributes to a stronger and more resilient healthcare ecosystem across three key dimensions:
01
Faster,
more reliable discovery:
Axxam’s discovery services sit at the start of the value chain for drug development. By raising the standard of every output, Axxam helps ensure that innovations reaching patients are more reliable, responsible, and commercially competitive for the partners and clients that carry them forward on a global scale.
02
Enabling innovation
where it matters most:
Axxam services address both widespread and underserved medical needs, ultimately contributing to improved patient outcomes and quality of life. Its role in early-stage discovery enables partners and clients to identify and advance more effective treatment candidates, particularly for complex and high-impact diseases. This increases the likelihood that meaningful therapies reach patients in a timely manner.
03
Strengthening the overall
efficiency of drug development:
Axxam’s contribution at the beginning of the value chain improves how the entire development process performs. Higher-quality inputs translate into more efficient pipelines, stronger clinical potential, and better commercial positioning for partners and clients.
Driving ecosystem impact
through sustainable operations
Axxam embeds sustainability across its operations and partnerships, ensuring that its scientific outputs deliver meaningful societal impact while contributing to the resilience and advancement of the broader life sciences ecosystem.
Strengthening value chains through responsible sourcing
Sustainability considerations are embedded into procurement practices, shaping how suppliers operate and engage with the life sciences sector. Laboratory suppliers and service providers are assessed against environmental and ethical criteria, ensuring alignment with rising regulatory requirements and industry standards.
Reinforcing trust through governance and ethical standards
Governance frameworks, quality systems, and compliance practices underpin the reliability of Axxam’s work. Standardized methodologies and strict regulatory alignment ensure that data is reproducible, traceable, and credible, enabling clients to move forward with confidence in development and approval processes.
Advancing sustainable laboratory practices:
Axxam continues to improve the environmental performance of its laboratory operations through its My Green Lab certification process. Efforts focus on reducing energy use, water consumption, and material waste in environments that are inherently resource-intensive, strengthening operational efficiency while limiting environmental impact.
Highlights…
reduction in total GHG emissions 2025 vs 2024
of main suppliers assessed on ESG criteria
of employees trained on integrity, safety, and ethics
Certifications & recognitions
Discover more case studies
Smile: Enabling sustainable digital transformation across the value chain
When IT, construction, and sustainability meet: Sogelink’s role in the future of infrastructure
Nomios: Enabling secure and sustainable digital transformation
3PBiovian: Strategic approach to workforce excellence
